Search research articles
Contact Us
Filters
Showing results (801-810 of 1,095) with videos related to
Page
of 110
Sort By:
Future Oncology (London, England)
|
May 19, 2018
Negative prognostic factors and resulting clinical outcome in patients with metastatic renal cell carcinoma included in the Italian nivolumab-expanded access program
Sergio Bracarda, Luca Galli, Marco Maruzzo, et al.
Alimentary Pharmacology & Therapeutics
|
January 19, 2021
Incremental value of HBcrAg to classify 1582 HBeAg-negative individuals in chronic infection without liver disease or hepatitis
Maurizia R Brunetto, Ivana Carey, Benjamin Maasoumy, et al.
Cancer Medicine
|
March 21, 2022
Effect of systemic therapies or best supportive care after disease progression to both nivolumab and cabozantinib in metastatic renal cell carcinoma: The Meet-Uro 19BEYOND study
Giandomenico Roviello, Elisabetta Gambale, Roberta Giorgione, et al.
Hepatology (Baltimore, Md.)
|
January 22, 2011
Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease
Yun-Fan Liaw, I-Shyan Sheen, Chuan-Mo Lee, et al.
Antimicrobial Agents and Chemotherapy
|
December 17, 2014
Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in treatment-naive patients with chronic hepatitis C virus infection and advanced liver fibrosis or cirrhosis
Stefan Zeuzem, Vicente Soriano, Tarik Asselah, et al.
Therapeutic Advances in Urology
|
April 19, 2024
Assessing the effectiveness and safety of lenvatinib and everolimus in advanced renal cell carcinoma: insights from the RELIEVE study's analysis of heavily pretreated patients
Sebastiano Buti, Alessandro Olivari, Cristina Masini, et al.
Clinical Genitourinary Cancer
|
April 17, 2024
Real World Analysis of Peritoneal Metastasis From Renal Cell Carcinoma. Meet-Uro27
Marco Stellato, Sebastiano Buti, Marco Maruzzo, et al.
Scientific Reports
|
February 19, 2021
Sophisticated viral quasispecies with a genotype-related pattern of mutations in the hepatitis B X gene of HBeAg-ve chronically infected patients
Maria Francesca Cortese, Carolina González, Josep Gregori, et al.
Frontiers in Oncology
|
June 25, 2021
Impact of Previous Nephrectomy on Clinical Outcome of Metastatic Renal Carcinoma Treated With Immune-Oncology: A Real-World Study on Behalf of Meet-URO Group (MeetUro-7b)
Marco Stellato, Daniele Santini, Elena Verzoni, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 26, 2023
The role of the caregiver in older patients with advanced prostate cancer: results from the ADHERE Prospective Study of the Meet-URO network
Emilio Francesco Giunta, Silvia De Padova, Shobana Anpalakhan, et al.
Page
of 110
Search research articles
Search
Showing results (801-810 of 1,095) with videos related to
Sort By:
Page
of 110
Future Oncology (London, England)
|
May 19, 2018
Negative prognostic factors and resulting clinical outcome in patients with metastatic renal cell carcinoma included in the Italian nivolumab-expanded access program
Sergio Bracarda, Luca Galli, Marco Maruzzo, et al.
Alimentary Pharmacology & Therapeutics
|
January 19, 2021
Incremental value of HBcrAg to classify 1582 HBeAg-negative individuals in chronic infection without liver disease or hepatitis
Maurizia R Brunetto, Ivana Carey, Benjamin Maasoumy, et al.
Cancer Medicine
|
March 21, 2022
Effect of systemic therapies or best supportive care after disease progression to both nivolumab and cabozantinib in metastatic renal cell carcinoma: The Meet-Uro 19BEYOND study
Giandomenico Roviello, Elisabetta Gambale, Roberta Giorgione, et al.
Hepatology (Baltimore, Md.)
|
January 22, 2011
Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease
Yun-Fan Liaw, I-Shyan Sheen, Chuan-Mo Lee, et al.
Antimicrobial Agents and Chemotherapy
|
December 17, 2014
Efficacy and safety of faldaprevir, deleobuvir, and ribavirin in treatment-naive patients with chronic hepatitis C virus infection and advanced liver fibrosis or cirrhosis
Stefan Zeuzem, Vicente Soriano, Tarik Asselah, et al.
Therapeutic Advances in Urology
|
April 19, 2024
Assessing the effectiveness and safety of lenvatinib and everolimus in advanced renal cell carcinoma: insights from the RELIEVE study's analysis of heavily pretreated patients
Sebastiano Buti, Alessandro Olivari, Cristina Masini, et al.
Clinical Genitourinary Cancer
|
April 17, 2024
Real World Analysis of Peritoneal Metastasis From Renal Cell Carcinoma. Meet-Uro27
Marco Stellato, Sebastiano Buti, Marco Maruzzo, et al.
Scientific Reports
|
February 19, 2021
Sophisticated viral quasispecies with a genotype-related pattern of mutations in the hepatitis B X gene of HBeAg-ve chronically infected patients
Maria Francesca Cortese, Carolina González, Josep Gregori, et al.
Frontiers in Oncology
|
June 25, 2021
Impact of Previous Nephrectomy on Clinical Outcome of Metastatic Renal Carcinoma Treated With Immune-Oncology: A Real-World Study on Behalf of Meet-URO Group (MeetUro-7b)
Marco Stellato, Daniele Santini, Elena Verzoni, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
June 26, 2023
The role of the caregiver in older patients with advanced prostate cancer: results from the ADHERE Prospective Study of the Meet-URO network
Emilio Francesco Giunta, Silvia De Padova, Shobana Anpalakhan, et al.
Page
of 110